Cargando…

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism

Parkinson’s disease (PD) is a neurodegenerative disorder of unknown etiology. The main treatment of PD consists of medication with dopamine-based drugs, which palliate the symptoms but may produce adverse effects after chronic administration. Accordingly, there is a need to develop novel neuroprotec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Soler, Maricel, Cordobilla, Begoña, Morató, Xavier, Fernández-Dueñas, Víctor, Domingo, Joan C., Ciruela, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127646/ https://www.ncbi.nlm.nih.gov/pubmed/30233293 http://dx.doi.org/10.3389/fnins.2018.00604

Ejemplares similares

Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice
por: Mancera, Pilar, et al.
Publicado: (2017)

Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A(2A) and dopamine D(2) receptors
por: Guixà-González, Ramon, et al.
Publicado: (2016)

Uncovering Caffeine’s Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2014)

Revealing Adenosine A(2A)-Dopamine D(2) Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2019)

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
por: Castillo, Félix, et al.
Publicado: (2021)

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2015)

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term
por: Castillo Salinas, Félix, et al.
Publicado: (2022)

Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
por: Ayats-Vidal, Roser, et al.
Publicado: (2023)

The Parkinson’s disease-associated GPR37 receptor interacts with striatal adenosine A(2A) receptor controlling its cell surface expression and function in vivo
por: Morató, Xavier, et al.
Publicado: (2017)

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease
por: Boyer-Diaz, Zoe, et al.
Publicado: (2019)

Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2018)

Adenosine A(1)-A(2A) Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial
por: Rodríguez, Celestino, et al.
Publicado: (2019)

Ecto-GPR37: a potential biomarker for Parkinson’s disease
por: Morató, Xavier, et al.
Publicado: (2021)

Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
por: Lafuente, María, et al.
Publicado: (2021)

G protein-coupled receptor 37 (GPR37) emerges as an important modulator of adenosinergic transmission in the striatum
por: Morató, Xavier, et al.
Publicado: (2019)

Antioxidant and Anti-Inflammatory Effects of Oral Supplementation with a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients with Keratoconus: A Randomized Controlled Preliminary Study
por: Peris-Martínez, Cristina, et al.
Publicado: (2023)

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
por: Drobnic, Franchek, et al.
Publicado: (2017)

Development of a Novel σ(1) Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells
por: Morató, Xavier, et al.
Publicado: (2023)

Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window
por: Eady, Tiffany N, et al.
Publicado: (2012)

Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
por: Sambra, Verónica, et al.
Publicado: (2021)

Molecular and Signaling Mechanisms for Docosahexaenoic Acid-Derived Neurodevelopment and Neuroprotection
por: Kim, Hee-Yong, et al.
Publicado: (2022)

Functional and Neuroprotective Role of Striatal Adenosine A(2A) Receptor Heterotetramers
por: Ferré, Sergi, et al.
Publicado: (2019)

Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke
por: Belayev, Ludmila, et al.
Publicado: (2010)

Portraying G Protein-Coupled Receptors with Fluorescent Ligands
por: Ciruela, Francisco, et al.
Publicado: (2014)

Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
por: Castro-Marrero, Jesús, et al.
Publicado: (2022)

Genetic risk prediction of the plasma triglyceride response to independent supplementations with eicosapentaenoic and docosahexaenoic acids: the ComparED Study
por: Vallée Marcotte, Bastien, et al.
Publicado: (2020)

Quantitative Proteomics Reveals Docosahexaenoic Acid-Mediated Neuroprotective Effects in Lipopolysaccharide-Stimulated Microglial Cells
por: Yang, Bo, et al.
Publicado: (2020)

Intravitreal Docosahexaenoic Acid in a Rabbit Model: Preclinical Safety Assessment
por: Dolz-Marco, Rosa, et al.
Publicado: (2014)

Pridopidine Reverses Phencyclidine-Induced Memory Impairment
por: Sahlholm, Kristoffer, et al.
Publicado: (2018)

Neuroprotective Treatments for Digestive Forms of Chagas Disease in Experimental Models: A Systematic Review
por: do Carmo Neto, José Rodrigues, et al.
Publicado: (2022)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
por: Koppula, Sushruta, et al.
Publicado: (2012)

Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging
por: Fernandez, Regina F., et al.
Publicado: (2021)

Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Castro-Marrero, Jesús, et al.
Publicado: (2021)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson’s Disease
por: Shinko, Aiko, et al.
Publicado: (2014)

Neuroprotective effect of docosahexaenoic acid nanoemulsion on erectile function in a rat model of bilateral cavernous nerve injury
por: Liao, Chun-Hou, et al.
Publicado: (2016)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a2l2s8ns4qsua6jvig9nv6nm3n